Ιnternational Mergers & Acquisitions:Rosemont Pharmaceuticals
Rokas Law Firm is proud to have advised Rosemont Pharmaceuticals on the recent share acquisition of the Greek company Pharma-Data S.A.
UK-based Rosemont Pharmaceuticals Ltd, a leading company in the development, production, and distribution of pharmaceuticals in liquid form for over 50 years, has acquired the Greek private research and development company Pharma-Data S.A., as announced last Thursday.
Pharma-Data, based in Lavrio close to Cape Sounion, specializes in the research and development of value-added pharmaceutical products for Europe and the US and has its own R&D design laboratory in Athens which is certified in terms of Good Manufacturing Practice (GMP) by Greece’s National Medicines Organization (EOF).
The company also provides development, dossier drafting, technology transfer, licensing, and regulatory services for pharmaceuticals on a global basis.
Our legal team included Partner Alkistis Christofilou alongside Senior Associates Sofia Getimi, Marily Garyfallou, Angela Moisidou and Associates Xenia Kretsovali and Elli Fenekou. Rosemont was supported by the law firm Trowers and Hamlins in the UK.
Rokas Law Firm assists clients in seamlessly navigating through the stages of complex transactions.
Howard Taylor, CEO of Rosemont, said: “The acquisition of and access to Pharma-Data is both exciting and important for Rosemont Pharmaceuticals. Firstly, it reinforces our commitment to develop innovative, patient-centred medicines for patients who cannot swallow tablets, and secondly, it is Rosemont’s first step toward expansion through international subsidiaries beyond the UK. Everyone at Rosemont is looking forward to working with the team in Greece.”
